Part D Premiums ‘Won’t Go Up’ With HHS Rebate Proposal, Azar Maintains

US HHS secretary tells Senate Finance Committee he believes pharmacy benefit managers will effectively keep drug costs down in Medicare Part D, even without rebates.

Alex Azar, Trump’s HHS secretary nominee, who spoke at the Senate HELP committee 11/29/17
Secretary Alex Azar at a previous congressional hearing.

The HHS proposal to eliminate prescription drug rebates in Medicare Part D will not lead to increased premiums and government spending despite some projections to the contrary, US HHS Secretary Alex Azar assured the Senate Finance Committee at a March 14 hearing.

The hearing focused on the President’s budget proposal for 2020. At the session, Azar fielded questions on a wide range...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Medicare

More from Government Payers